Cardinal Health, Inc. (LON:0HTG)
202.62
+7.42 (3.80%)
At close: Nov 7, 2025
Cardinal Health Revenue
Cardinal Health had revenue of $64.01B USD in the quarter ending September 30, 2025, with 22.44% growth. This brings the company's revenue in the last twelve months to $234.31B, up 4.39% year-over-year. In the fiscal year ending June 30, 2025, Cardinal Health had annual revenue of $222.58B, down -1.87%.
Revenue (ttm)
$234.31B
Revenue Growth
+4.39%
P/S Ratio
0.21
Revenue / Employee
$4.06M
Employees
57,700
Market Cap
36.75B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 222.58B | -4.25B | -1.87% |
| Jun 30, 2024 | 226.83B | 21.85B | 10.66% |
| Jun 30, 2023 | 204.98B | 23.65B | 13.04% |
| Jun 30, 2022 | 181.33B | 18.86B | 11.61% |
| Jun 30, 2021 | 162.47B | 9.55B | 6.24% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Cardinal Health News
- 1 day ago - Should Value Investors Buy Cardinal Health (CAH) Stock? - Nasdaq
- 2 days ago - 3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH) - Nasdaq
- 3 days ago - Cardinal Health: Quiet Transformation, Clear Buy - Seeking Alpha
- 3 days ago - Wells Fargo Raises Price Target for Cardinal Health (CAH) to $221 | CAH Stock News - GuruFocus
- 3 days ago - Cardinal Health (CAH) Boosts FY 2026 EPS Guidance - GuruFocus
- 4 days ago - Increasing medication access: Charitable clinics and pharmacies to receive share in $1.6 million in Equity Rx grants from Cardinal Health Foundation - GlobeNewsWire
- 4 days ago - Cardinal Health Board of Directors Approves Quarterly Dividend - PRNewsWire
- 5 days ago - Mizuho Raises Price Target for Cardinal Health (CAH) to $210 | CAH Stock News - GuruFocus